BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23007470)

  • 1. Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway.
    Song HB; Park KD; Kim JH; Kim DH; Yu YS; Kim JH
    Oncol Rep; 2012 Dec; 28(6):2057-62. PubMed ID: 23007470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways.
    Lee BJ; Kim JH; Woo SH; Kim JH; Kim DH; Yu YS
    Oncol Rep; 2011 Sep; 26(3):665-70. PubMed ID: 21617868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
    Xu Z; Maiti D; Kisiel W; Duh EJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
    Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
    J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
    Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
    Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
    Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues].
    Wu JH; Xu P; Yi MY; Wang F; Wang XL; Huang Q
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):419-22. PubMed ID: 15938806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
    Cui P; Yu M; Peng X; Dong L; Yang Z
    J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
    Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
    Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways.
    Huh JE; Nam DW; Baek YH; Kang JW; Park DS; Choi DY; Lee JD
    Int Immunopharmacol; 2011 Jan; 11(1):46-54. PubMed ID: 20959155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins.
    Provençal M; Michaud M; Beaulieu E; Ratel D; Rivard GE; Gingras D; Béliveau R
    Thromb Haemost; 2008 Mar; 99(3):576-85. PubMed ID: 18327407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway.
    Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M
    Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.